Sharon Osbourne has expressed regret over taking the drug Ozempic for weight loss.
"I'm through with the weight loss and all that cosmetic stuff," she told The Guardian.
Osbourne, 71, says she now weighs less than 100 pounds and "can't put on weight."
Sharon Osbourne has expressed regret over taking the drug Ozempic for weight loss, saying she now weighs less than 100 pounds and "can't put on weight."
In an interview with The Guardian, Osbourne, 71, highlighted the downsides of Ozempic, a buzzy diabetes drug that also causes weight loss. She said that after dropping "too much" weight, 42 pounds in four months, she was "through with the weight loss and all that cosmetic stuff."
"I was injecting myself with Ozempic," Osbourne said, adding: "I now weigh 7 stone and can't put on weight." In British weight measurement, a stone is equivalent to 14 pounds.
Osbourne has previously talked about her experience taking the drug for weight loss. In an interview with the Daily Mail last year, she warned those interested in taking Ozempic to "be careful what you wish for."
"You can lose so much weight, and it's easy to become addicted to that, which is very dangerous," she said. "I couldn't stop losing weight, and now I've lost 42 pounds, and I can't afford to lose any more."
"I started on Ozempic last December, and I've been off it for a while now, but my warning is don't give it to teenagers; it's just too easy," she added.
Ozempic is a brand name for semaglutide, an FDA-approved drug used to treat diabetes. Also sold under the brand names Wegovy and Rybelsus, semaglutide has surged in popularity since it was approved by the FDA as a treatment for obesity in 2021.
Dozens of A-listers have acknowledged their use of semaglutide, including Elon Musk, Charles Barkley, and Amy Schumer.
The drug works by suppressing appetite, but side effects such as muscle loss, nausea, and diarrhea have been reported. A doctor previously told Business Insider it was common to regain the weight after stopping treatment.
She said a facelift she got in 2021 had left her looking like a cyclops and was the "worst thing" she'd ever done.
Correction: February 12, 2024 — An earlier version of this story misstated the year that semaglutide was approved by the FDA as a treatment for obesity. It was 2021, not 2022.
Read the original article on Business Insider